Biorestorative TherapiesBRTX
13F holders, Q1 2026 (March 31)11holders −2
2new positions
4sold out
1famous investor
$0.27avg. 13F price*
At the end of Q1 2026, 11 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, down 2 from Q4 2025. 2 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($65K), Geode Capital Management, LLC ($61K) and UBS Group AG ($27K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Biorestorative Therapies Inc.
- CUSIP
- 090655606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $27K |
| Exits | 4 | $89K |
All 13F filers, Q4 2025 → Q1 2026: 474,906 shares bought and 75,644 shares sold, net +399,262 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Citadel Advisors | 0.00% | Add +717.2% | 238,606 | $65K |
| Geode Capital Management, LLC | 0.00% | Add +285.6% | 223,083 | $61K |
| UBS Group AG | 0.00% | New | 99,832 | $27K |
| Wealth Alliance, LLC | 0.00% | No change | 40,000 | $11K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 39,452 | $11K |
| State Street Corp. | 0.00% | No change | 32,459 | $9K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $540 |
| Tower Research Capital LLC (TRC) | 0.00% | Add +32.2% | 1,462 | $398 |
| SBI Securities Co., Ltd. | 0.00% | Add +67.2% | 199 | $54 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 3 | $1 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.